What we know about investments in hepatitis and the need for new advocacy tools Chris Taylor, Associate Director, Viral Hepatitis AIDS 2012 – Global Village.

Slides:



Advertisements
Similar presentations
John Sanbrailo Executive Director CAAP Meeting Organization of American States October 5, 2012.
Advertisements

Advocating for Sectors on Capitol Hill NNSP National Conference Planning Call - October 21, 2009.
Childrens Cabinet Network webinar with the Federal Interagency Working Group on Youth Programs February 15, PM EST.
RMAWG MEETING June 2012 Brussels DISTRICT BUDGET ADVOCACY By Josiah Otege Policy & Advocacy Officer Marie Stopes Tanzania.
1 David Kathan, Ph.D Federal Energy Regulatory Commission 2010 National Town Meeting on Demand Response and Smart Grid June 23, 2010 National Action Plan.
ADDC Practitioner Interest Forum: International Cooperation 1 ADDC Practitioner Interest Forum International Cooperation Paul Deany ADDC Executive Committee.
Global Fund Investments in Harm Reduction Washington, July 2012 Global Fund Investments for People Who Inject Drugs 23 July 2012 Professor Jeffrey V. Lazarus.
TBD-UK: The UK response in the discovery and development of new TB drugs. Dr Geoff Coxon Deputy Leader & Director of Medicinal Chemistry, TBD-UK APPG-TB.
World Health Organization
Working world wide against HIV for the health and human rights of men who have sex with men Working world wide against HIV for the health and human rights.
HIAC Campaign Tools GFAN Strategy Meeting Tuesday, January 29, 2013, Amsterdam Presenter: Heather Benjamin, OSF/ ICSS Consultant.
HRSA Policy Updates NASTAD AIDS Drug Assistance Program (ADAP) Technical Assistance Meeting July 31, 2014 Heather Hauck, Director Division of State HIV/AIDS.
Dr. E. Anne Peterson, MD, MPH Assistant Administrator, Bureau for Global Health, USAID Sustainable Investment and Donor Coordination Stop TB Partners Forum.
1 Raising Funds for Your Vision Ruth Mageria Director of Fundraising Nairobi Chapel
Building Effective Advocacy for Hepatitis C Hepatitis C Choices in Care.
Key Themes. What is your story? What part of it will tug at the emotions of prospective donors? How will you go about creating your story?
Evaluating the Impact of Integrating Viral Hepatitis Services for HIV and STD Prevention Moderator: Danni Lentine.
The Public Health Revitalization Act A look at what this means for you and examples from Washington State. Michael Wallingford, MPA, REHS Colorado Directors.
The Community Investment Triangle Targeting Our Resources Part 3: Aligning Around Strategies for Impact.
ACSM MEETING A Centre for Resource Mobilization by Louise Baker, Stop TB Secretariat.
T reatment A ction G roup Update on Global TB Research By Claire Wingfield Treatment Action Group Advisory Council for the Elimination of Tuberculosis.
Partnerships in Promoting Innovation and Managing Risk Scientific and Financial Innovation in AIDS Vaccines International AIDS Vaccine Initiative Labeeb.
Challenge to End Malnutrition Strategic Fundraising Plan for a Five Year ACF International Campaign Presentation to ACF-F Conseil d’Administration 8 October.
Peer Education and Advocacy and the School Based Health Center Experience Annika Shore Youth HIV Education Coordinator Cascade AIDS Project Teen2Teen peer.
Strategies for Fostering International Linkages by Chris Whatley Former CSG Washington Office Director.
Colorado Department of Public Health and Environment Tuberculosis Prevention and Control Program.
Washington D.C., USA, July 2012www.aids2012.org Know Your Resources: How to use funding data to strengthen your messages in the critical push for.
Vaccine Quo Vadis? 20 July 2010 Alan Bernstein, O.C., Ph.D. Executive Director, Global HIV Vaccine Enterprise.
Supporting community action on AIDS in developing countries Costing Community Mobilization: An NGO Perspective Jason Taylor Wright, MSFS, MA U.S. Director.
The AIDS Vaccine Policy Agenda Holly J. Wong Vice President, Public Policy International AIDS Vaccine Initiative (IAVI) Vienna, Austria International AIDS.
Global Estimates of People Living with HIV/AIDS SOURCE: UNAIDS, Report on the Global AIDS Epidemic, In Millions.
High-level forum on strategic planning for statistics: Bangkok, 6-8 June 2006 Advocacy for statistics Presentation by PARIS21 Secretariat High-level forum.
The Hepatitis C Treatment Access Crisis Ryan Clary Executive Director May 22, 2015.
Doing more of the same is not sustainable. Commissioning Journey.
Business Council of Alabama (5,000) + Chamber of Commerce Association of Alabama (120=60,000) Alabama School Readiness Alliance (GR, FND, A,E) Alabama.
HIV/AIDS The times they are a changing Roxana Rogers David Stanton Office of HIV/AIDS.
FUNDING & FINANCE Presented by Brock Crawford and Amber Bagwell.
CDC’s Investments in Community Initiatives Division of Adult and Community Health National Center for Chronic Disease Prevention and Health Promotion Lynda.
The HIV Response Where are we now?
Federal Welcome: A View from the Office of HIV/AIDS and
Name(s) Here Job Title(s) Here.
Policy Update Michael Ruppal Executive Director, The AIDS Institute
20:20 Vision Making new and old money work better
H. Dawn Fukuda, Director Office of HIV/AIDS
Hepatitis C Allies of Philadelphia August 2, 2017
Financing for the long haul: Elimination of Epidemics of AIDS and Viral Hepatitis Alan Whiteside OBE Chair in Global Health Policy, Balsillie School of.
12. Role of national and international technical and funding partners in the implementation of aDSM Multi-partner training package on active TB drug safety.
The Power of Many Voices: Increasing HIV, STD and Viral Hepatitis Integration 2008 National STD Prevention Conference March 11, 2008 Introduce yourself.
Donor Government Disbursements for HIV,
The Role of Public Health in Hepatitis Elimination
Broadening the HIV Prevention Landscape Dade Community Foundation
Donor Government Disbursements for HIV,
U.S. Funding for Global Malaria, FY 2001 – FY 2019 Request
U.S. Global Health Funding, FY 2006-FY 2017 Request
U.S. Global Health Funding, By Sector, FY 2006-FY 2016 Request
U.S. Global Health Funding for the President’s Emergency Plan for AIDS Relief (PEPFAR), FY 2001-FY 2013* In Millions *FY 2012 are final estimates; FY 2013.
NASTAD Update CSTE Annual Conference
Showing throughout the event
U.S. Global Health Funding: Bilateral Malaria, FY FY 2017 Request
U.S. Global Health Funding, By Sector, FY 2019 Request
ENDING THE EPIDEMICS: A FOCUS ON PEOPLE WHO INJECT DRUGS
U.S. Funding for Bilateral HIV, FY 2001 – FY 2019 Request
NOTES: PEPFAR was created in 2003 and funding began in FY04
U.S. Funding for the President’s Emergency Plan for AIDS Relief (PEPFAR), FY 2004-FY 2018 Request In Millions NOTES: PEPFAR was created in 2003 and funding.
U.S. Global Health Funding: President’s Emergency Plan for AIDS Relief (PEPFAR), FY 2004-FY 2017 Request In Millions NOTES: PEPFAR was created in 2003.
Transportation Finance Tools
2013 Nonprofit Information Session
PARIS21 Work Programme
HIV Funding from Donor Governments,
Advancing STD Prevention as Public Health Priority
Presentation transcript:

What we know about investments in hepatitis and the need for new advocacy tools Chris Taylor, Associate Director, Viral Hepatitis AIDS 2012 – Global Village Session July 23, 2012

The Budget Landscape  Very little funding dedicated to viral hepatitis –US – CDC Division of Viral Hepatitis ~$30 million –US – NIH ~$100 million –US – Other agencies – very little to no dedicated funding –WHO – very few staff assigned to viral hepatitis  Need greatly outweighs available funding  Relying on public/private partnerships

How You Can Help!  Work with hepatitis advocates in your area  Assist with identifying hepatitis funding while conducting HIV resource tracking  Carry hepatitis advocacy messages  Look at co-infection rates and develop a strategy  Ask like-minded donors to consider hepatitis also  Share your expertise about resource tracking

 World Hepatitis Alliance –  National Viral Hepatitis Roundtable – Chris Taylor Associate Director, Viral Hepatitis